Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD

Slides:

Advertisements

Similar presentations

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Volume 131, Issue 4, Pages (April 2007)

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Suppurative Salmonella thyroiditis coexistence with invasive thymoma

Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management Delphine Trousse, MD, Fabrice Barlesi,

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease Chung-Ping Hsu, MD,

Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer Gaurav S. Ajmani, MHS, Chi-Hsiung.

Lung cancer screening: No more excuses

Supine position with alternating inflation pneumatic cuffs in video-assisted thoracoscopic surgery for bilateral pneumothorax Pei-Ming Huang, MD, Yih-Leong.

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Results of Surgical Treatment for Patients with Small Cell Lung Cancer

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Esophageal atypical carcinoid tumor with tracheal invasion

Survival after resection of synchronous non–small cell lung cancer

Intrinsic cardiac stem cells are essential for regeneration

Factors predictive of prognosis after esophagectomy for squamous cell cancer Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single- institution experience Bin Li, MD, Haiquan Chen, MD, Jiaqing Xiang,

Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non–small cell lung.

Marye J. Gleva, MD, Charles B. Huddleston, MD

Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry Bing-Yen Wang, MD, Jing-Yang Huang, Ching-Yuan Cheng, MD, Ching-Hsiung Lin, MD,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal.

Lung adenocarcinoma: Are skip N2 metastases different from non-skip?

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus Po-Kuei.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

A fate worse than death Jennifer S. Lawton, MD

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Carcinoma of the esophagus: Prognostic significance of histologic type

O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

The harder one looks, the more one finds

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

“The more things change…”: The challenges ahead

Why arch curvature affects arch resistance

Kiran H. Lagisetty, David G. Beer, Andrew C. Chang

Aritoshi Hattori, MD, Kenji Suzuki, MD

More than vital: Who bears the burden?

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

Surgical treatment of synchronous multiple primary lung cancers: Experience of 92 patients Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 134, Issue 3, Pages 630-637 (September 2007) DOI: 10.1016/j.jtcvs.2007.06.001 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Patients with MPLC with lymph node metastasis tended to have worse survival compared with patients without lymph node metastasis (P < .001, log–rank test). MPLC, multiple primary lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 630-637DOI: (10.1016/j.jtcvs.2007.06.001) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Comparison of survival curves of patients with or without extranodal extension (P = .005, log–rank test). The Journal of Thoracic and Cardiovascular Surgery 2007 134, 630-637DOI: (10.1016/j.jtcvs.2007.06.001) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Comparison of survival curves of patients with or without vascular invasion (P = .010, log–rank test). The Journal of Thoracic and Cardiovascular Surgery 2007 134, 630-637DOI: (10.1016/j.jtcvs.2007.06.001) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Survival curves of patients with MPLC with bronchioloalveolar carcinoma, adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, and different histologic types (P = .049, log–rank test). MPLC, Multiple primary lung cancer; SCC, Squamous cell carcinoma; BAC, bronchioloalveolar carcinoma; ASC, adenosquamous carcinoma; DH, different histology. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 630-637DOI: (10.1016/j.jtcvs.2007.06.001) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions